Johnson & Johnson wins U.S. FDA approval for bladder cancer drug

34

Johnson & Johnson’s drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced on Friday.

http://feeds.reuters.com/~r/reuters/healthNews/~3/1TReT5WIsn8/johnson-johnson-wins-u-s-fda-approval-for-bladder-cancer-drug-idUSKCN1RO27E